Radiologex Introduces R-DEE Protocol Network and Commences Limited RDGX Token Pre-Sale for Healthcare IT Revolution

Radiologex Technologies Ltd. proudly launches the groundbreaking R-DEE Protocol™ Network, a bespoke blockchain solution catering to the global healthcare IT sector. After five years of extensive research and development, Radiologex presents the R-DEE Protocol Network alongside the R-DEE suite—an advanced health IT productivity software tailored for the healthcare industry.

Key Highlights:

Limited RDGX Token Pre-Sale:

• Radiologex announces an exclusive Pre-Sale event for RDGX tokens, offering a highly limited 2.5 million tokens to investors.
• The pre-sale underscores the exclusivity and anticipated high demand for this consequential digital asset.

Purpose-Driven Utility:

• Radiologex's self-bootstrapped R-DEE Protocol Network is ready for investment, ensuring a complete and operational product.
• Emphasizes commitment to delivering a fully realized, enterprise-grade solution, enhancing buyer confidence.

R-DEE Protocol Network Features:

• Introduces economic incentives for Node Validators with a cap of 12,500 Node Validator licenses, offering distinct significance for each Validator.
• Node Validators secure Digital IDs and audit trails for global secure healthcare data transfer, requiring a commitment of 10,000 RDGX tokens for a Node Validator License.

Node Validator Incentives:

• Node Validators can earn 300 RDGX tokens every 30 days, showcasing a substantial 3% monthly earning potential and an impressive annual yield of 36%.

Visionary Leap Forward:

• Radiologex's R-DEE Protocol Network and RDGX token demonstrate compelling use cases in blockchain and digital asset sectors.
• RDGX token signifies the future of healthcare IT, validating security, validation, and practicality.

CEO Statement:

• John K. Smith, CEO of Radiologex Technologies Ltd., highlights the transformative impact on healthcare IT, marking a significant stride for the entire healthcare realm.

Invitation to Join:

• Radiologex invites participation in the RDGX token pre-sale, inviting stakeholders to pioneer the future of healthcare technology.